Search

everythinglearnresearchcommunity

for

Search:↓

IL-24 contributes to skin aging by increasing collagen-degrading enzymes and decreasing collagen production when exposed to air pollution.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Topical ruxolitinib failed to regrow hair in a 66-year-old with alopecia areata.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

Melatonin affects gene expression in goat hair follicles, potentially increasing cashmere production.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Keratin protein production in cells is controlled by a complex system that changes with cell type, health, and conditions like injury or cancer.

Platelet lysate effectively promotes hair growth and improves hair thickness in people with androgenetic alopecia.

Researchers found genes linked to feather growth speed in Shouguang chickens, highlighting two genes that might explain differences in feathering.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.

The research found specific genes and pathways that control fur development and color in young American minks.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

TLR2 helps control hair growth and regeneration, and its reduction with age or obesity can impair hair growth.

DN106212, an extract from a plant, is better at promoting hair growth than other tested substances by affecting hair growth factors and follicle development.

An 11-year-old girl with severe hair loss was successfully treated with a new combination therapy.

The review provided information on various treatments to stop hair thinning and increase hair density in people with common genetic hair loss.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Metabolic signals and cell shape influence how cells develop and change.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

The review concluded that keeping the hair-growing ability of human dermal papilla cells is key for hair development and growth.

Stress in hair follicle stem cells causes inflammation in a chronic skin condition through a specific immune response pathway.

Hair follicle stem cells help maintain skin health and could improve skin replacement therapies.